{"cluster": 38, "subcluster": 10, "abstract_summ": "A liver and kidney transplant patient with SARS\u2010CoV\u20102 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti\u2010coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge.The emergence of this world pandemic is particularly important for solid organ transplant recipients, who might have an increased risk of mortality, not only due to their chronic immunosuppression status, but also to the cardiovascular risk that correlates with several years of chronic kidney disease.With the rapidly expanding pandemic of SARS\u2010CoV\u20102, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course.To the extent that there is still a lack of knowledge about the clinical characteristics, evolution and prognosis of SARS-CoV-2 infection in kidney transplant recipients, we will report the first 5 cases diagnosed and followed in our transplant unit, as well as share the therapeutic strategies adopted.After the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China, in December 2019, the contagion has spread rapidly and has become a global pandemic.1 There are as of yet no published studies beyond the case series describing the incidence and clinical course of COVID-19 in transplant recipients, a population potentially at high risk due to the ongoing immunosuppression and higher risk of comorbidities.2 This pandemic has had a major impact in transplant physicians and healthcare workers as well3 and this crisis has meant reducing or even interrupting transplant program activity, with a subsequent impact on patient morbidity and mortality that is still hard to quantify.", "title_summ": "SARS-CoV-2 infection in kidney transplant recipients.[SARS-CoV-2 infection and solid organ transplantation].Fatal outcome in a liver transplant recipient with COVID\u201019A case of coronavirus disease 2019\u2013infected liver transplant donorSolid Organ Transplantation During the COVID-19 PandemicEarliest cases of coronavirus disease 2019 (COVID\u201019) identified in solid organ transplant recipients in the United StatesCOVID\u201019 pneumonia in kidney transplant recipients\u2014Where we are?SARS\u2010CoV\u20102 pandemic and the need for transplant\u2010oriented trialsPreliminary data on outcomes of SARS\u2010CoV\u20102 infection in a Spanish single center cohort of kidney recipients", "title_abstract_phrases": "To the extent that there is still a lack of knowledge about the clinical characteristics, evolution and prognosis of SARS-CoV-2 infection in kidney transplant recipients, we will report the first 5 cases diagnosed and followed in our transplant unit, as well as share the therapeutic strategies adopted.[SARS-CoV-2 infection and solid organ transplantation].Transplantation has become a valid therapeutic option for an increasing number of patients with end-stage organ disease.Earliest cases of coronavirus disease 2019 (COVID\u201019) identified in solid organ transplant recipients in the United StatesWith the rapidly expanding pandemic of SARS\u2010CoV\u20102, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course.The emergence of this world pandemic is particularly important for solid organ transplant recipients, who might have an increased risk of mortality, not only due to their chronic immunosuppression status, but also to the cardiovascular risk that correlates with several years of chronic kidney disease.We report four cases of COVID\u201019 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants.These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID\u201019, including two hospitalized patients and two patients managed entirely in the outpatient setting."}